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Abstract
The gut microbiota collectively act as a metabolic organ supplying energy for themselves
and for the host they inhabit. This symbiotic relationship begins at the onset of a human
birth and continues throughout the lifespan. Who identifies as the more robust symbiote
has yet to be identified. The number of bacterial cells to human cells reveals a staggering
disparity. The majority of estimates place the total number of microbial cells on and in
the human body at 100 trillion, while the whole of the human contains 10 trillion. The
bacterial versus human genome is equally disconcerting as the number of bacterial genes
just within the human gut is estimated to be 3.3 million, while the whole human genome
contains approximately 20,000. Who controls whom? We live in a mutual coexistence
with our gut microbiota, but this affiliation occasionally becomes pathological, such as in
obesity. The evidence points towards the increased energy harvesting capabilities by the
intestinal bacteria promoting greater caloric availability to the host, thus allowing for
prodigious adiposity stores. The medical provider can accomplish effective mediation
through education. Not surprisingly, this education includes: increasing the number of
vaginal deliveries, reinforcing the need for breast feeding, decreasing unnecessary
antibiotic administrations, adopting a long-term low fat, high fiber diet, and committing
to long-term regular exercise. Key words and headings used for this literature review
included: microbiome, bacteria and obesity, gut bacteria, perturbation of microbiota,
antibiotics and obesity, commensal bacteria, sub-therapeutic antibiotic therapy, brain-gutaxis or BGA, microbiota-gut-brain axis or MGB axis, and human microbiome project.
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The Role of the Gut Microbiota in Obesity
The number of obese adolescents and adults in the United States has risen to an
all-time high of 53.5 percent of the population, and continues on a steep vertical
trajectory (CDC, 2015). The Centers for Disease Control estimates 80 percent of the
population within the United States will be considered obese by the year 2030, and 100
percent by the year 2048 (CDC, 2015). This epidemic is not isolated to the United States,
as worldwide obesity rates have more than doubled in the last twenty years (Devaraj,
Hemarajata, & Versalovic, 2013). The obesity epidemic affects all races, ages, genders,
and socioeconomic strati. As obesity rates increase, so do obesity related diseases, such
as hypertension, diabetes, cancer, and heart disease. Not only does obesity escalate
morbidity and mortality rates, but also conveys individual, communal, and pecuniary
consequences (Buhman, Roux, & Bueter, 2014). The prevailing wisdom, on the genesis
of obesity, has been predicated on the notion that an increase in caloric intake coupled
with a decrease in physical activity results in weight gain for anyone, regardless. While
this element is true, it is not an absolute verity (Devaraj, Hemarajata, & Versalovic,
2013). There are numerous factors and dimensions, which play a role in how an
individual attains the status of obese. One such factor that has eluded scrutiny involves
the ubiquitous microscopic life forms known as bacteria.
Bacteria occupy almost every surface on Earth, but humans were oblivious to
their existence until 1665 (Yong, 2016). Anton van Leeuwenhoek was not only the first
human to directly observe microscopic life in the world around him, but also the first
human to observe bacteria on his person, where in 1683, van Leeuwenhoek took samples
from his teeth and observed bacteria (Yong, 2016). Two hundred years would pass before
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bacteria would be identified as the progenitor of disease. The genesis for the germ theory
began in 1865 when French chemist Louis Pasteur demonstrated that bacteria were
responsible for decomposition and fermentation and later, it was theorized that bacteria
were responsible for disease (Yong, 2016). Pasteur’s experiments in germ theory were
replicated and scientifically proven by German physician and Nobel Prize winner Robert
Koch, in 1884. The late 19th century birthed a new secular worldview as Charles
Darwin’s concept of the relationship between living entities as a battle for existence
emerged. As a result of this conflict between the macro and the micro biospheres, it was
soon theorized that freedom from bacteria equated with independence from disease
(Yong, 2016). It was not until the turn of the 20th century that microbiologists began
describing bacteria as mutualistic and not solely in terms describing pathology of disease.
The devastating world war and the ensuing epidemics in the initial decades of the 1900’s
lead to the innovation that would severely curtail the reign of microbes and have
unforeseeable consequences.
Sir Alexander Fleming’s accidental discovery of penicillin in 1928 spawned a
pharmaceutical industry with over 100 antibiotics to date, and as a result, this discovery
has saved countless lives the world over (Collen, 2015). The attempted eradication of
opportunistic and pathogenic bacteria via antibiotics has improved morbidity and
mortality for those facing infections, and many individuals do not have the fear of death
or dismemberment that once afflicted people of two to three generations ago. In the
aftermath of 88 years of attempted global bacteriocide comes the unintended
consequence of an altered human microbiome, most notably within the individual’s small
and large intestines. The ensuing dysbiosis leads to life threatening Clostridium difficile
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infections, numerous antibiotic resistant microbes, and may be a contributing factor in the
obesity epidemic. The aim of this literature review will be to identify the microbiota
within the human gut, recognize how microbial life interacts with the host, and finally
ascertain how the human intestinal microbiota make a contribution to obesity.
Theoretical Framework
In an effort to direct this review of literature, the influences of the gut microbiome
will be investigated utilizing Betty Neuman’s Systems Model nursing theoretical
framework. Neuman’s theoretical framework defines the metaparadigms of nursing as:
(a) the client as an open system; (b) health as a continuum of wellness; (c) nursing as an
inimitable profession concerned with all variables impinging on an individual; and (d)
environment as all the internal and external circumstances enveloping the client structure
(Freese & Lawson, 2010). Neuman’s theoretical structure is comprised of two major
constituents: stress and methodical, or systematic, feedback loops (Freese & Lawson,
2010). In this way, the patient, or client, “…is an open system in which continual cycles
of input, processing, output, and feedback make up an active organizational pattern”
(Butts & Rich, 2010, p. 423).
According to Neuman’s theoretical framework, the patient, or client, resides at the
core of the nursing model and is surrounded by lines of defense and resistance. In this
literature review, the obese client, or a client with an altered gut microbiome will occupy
this core. The lines of defense will be represented by primary, secondary, and tertiary
prevention strategies, as well as the identification of stressors coming into contact with
the lines of defense. The health state of the client system will be dependent on the degree
of reaction within clients’ system, and the interventions enacted by the healthcare
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provider. According to Neuman’s model, the client suffers illness or disease when the
lines of defense and resistance are compromised, and the individual can no longer
maintain homeostasis. In this literature review, the threat to homeostasis will be
inappropriate antibiotic prescriptions. When there are compromises in the lines of defense
and resistance, and a threat to homeostasis is considered, nurse practitioner interventions
are required in order to allow the reconstitution of the lines and bring about homeostasis.
Ultimately, the use of the Neuman’s Systems Model can potentially identify the nurse
practitioner’s action of ordering an antibiotic for a client as helpful or harmful, thus
theoretically associating a distorted microbiome as a contributory factor in obesity.
PICO Question
The rates of obesity continue to increase despite the advancement of science,
technology, and healthcare. Corpulence is not a simple question of an imbalance of
calories in verses calories out, but is a multifaceted disease with numerous causes. In an
effort to address a portion of this complexity comes the query, does the microbiome of
the human gut occupy a niche in the obesity epidemic?
Review of Literature
A review of the literature was conducted from 2011 until 2016 from the following
databases: NIH Human Microbiome Project, PLoS One, ClinicalKey, CINAHL
complete, and Medline. Selected articles in the review of literature had to meet particular
criteria prerequisites to be included. These criteria included a publish date within the
previous five years, peer examined articles, full text availability at the database being
searched, and be available in the English language. This review of literature took place
between the months of May to December of 2016. The inquiry included the following
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key words and headings: microbiome, bacteria and obesity, gut bacteria, perturbation of
microbiota, antibiotics and obesity, commensal bacteria, sub-therapeutic antibiotic
therapy, brain-gut-axis or BGA, microbiota-gut-brain axis or MGB axis, and human
microbiome project. Searched information was limited to literature reviews,
comprehensive reviews, systematic reviews, and clinical trials. An extended search was
carried out utilizing the National Institute of Health, the Centers for Disease Control, the
Food and Drug Administration, and Up-To-Date, as well as medical textbooks and nonfiction science books. A total of one hundred and thirteen results were obtained, of which
twenty were chosen based on the information acquired from the abstracts provided with
the articles.
Categories
Microbial Convergences of the Human
The origin of microbial residency coincides with the birth of a human fetus. This
simultaneous cohabitation of human and bacterial cells takes place along the traditional
pathway, the vagina. As uterine contractions propel the fetus towards a hostile
environment he or she is encased in a moist covering of vaginal microbes. During the
birthing process no fetal body surface area is devoid of exposure. The infant’s eyes, nose,
mouth, and skin are all equally subjected. Later, as the baby emerges, normally face
down, he or she is exposed to the maternal fecal microbes (Collen, 2015). Alternately, the
widespread use of caesarean section introduces the infant to the potentially pathogenic
maternal microbial communities of the skin, as well as pathogenic microbial communities
of the procedural environment (Chu et al., 2016). The process of childbirth constitutes the
initial encounter of the infant with microorganisms capable of colonizing the infant’s
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intestinal tract, and sets the stage life-long co-habitation (Madan et al., 2016). Who, or
what, are these bacterial cells, which establish this potentially interdependent
relationship?
A study by Ravel et al. (2011) was performed in order to ascertain the vaginal
microbiome of reproduction-age women. This population based cohort study consisted of
four ethnic backgrounds; Caucasian, Black, Hispanic, and Asian, totaling 396 North
American women. The researchers had each female to collect mid-vaginal samples
utilizing two swabs. One swab was utilized to evaluate the vaginal microbial
communities on the basis of the Nugent criteria to diagnose bacterial vaginosis, and one
swab was employed to determine the vaginal microbial species composition (Ravel et al.,
2011).
Bacterial culturing was not employed. Instead, whole bacterial genomic DNA was
mined, and the bacterial genome was sequenced utilizing 16S rRNA pyrosequencing. A
total of 282 taxa were observed in the vaginal microbiota. The study by Ravel et al.
identified five major microbial communities and designated them as I, II, III, IV, and V
with 104, 25, 135, 108, and 21 taxa respectively. Group I communities were dominated
by Lactobacillus crispitans. Group II, III, and V communities were dominated by
Lactobacillus gasseri, L. iners, and L. jensenii. The study found that group IV was the
most diverse and was dominated by Prevotella, Sneathia, Megasphera, and
Streptococcus, all genera known to produce lactic acid. Vaginal bacterial groups
dominated by Lactobacillus, groups I, II, III, and V, were found in 80.2% of Asian and
Caucasian women, but only 59.6% and 61.9% in Hispanic and Black women. The
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individuals with vaginal bacterial communities not dominated by Lactobacillus were
predominately Black and Hispanic women (Ravel et al., 2011).
The study by Ravel et al. highlighted the differences of the various ethnic groups
in terms of what is considered a normal microbial community. This study identifies no
core microbiome for the human vagina, and the ratios of each microbial group varied
among the ethnic groups and were statistically significant, p < .0001 (Ravel et al. 2011).
Not only are there large numbers of various ethnicities, but also a diversity in relation to
the human vaginal microbiome housed with each individual within the ethnic group.
Understanding the various compositions of vaginal microbial communities allows the
practitioner to comprehend the probability that the maternal microbiome is hereditary.
A study by Madan et al. (2016) was conducted to observe the correlations of
delivery mode and feeding method with newborn intestinal microbiome structure at
approximately six-weeks of life. This longitudinal cohort study consisted of 102 infants,
which 70 were delivered vaginally, and 32 were delivered by cesarean section.
Additionally, 70 infants were exclusively breast-fed, 26 infants received a combination of
breast milk and formula, and six infants were fed exclusively formula (Madan et al.,
2016).
The results of this study highlighted five statistically significant findings. The first
finding was that the delivery mode was strongly associated with the infant’s gut
microbiome composition, p < .001. Secondly, there is a strong association between
feeding method and the infant’s stool microbial community composition, p < .001.
Thirdly, the infants fed exclusively by breast milk had microbial communities distinctly
different from the other feeding modalities, p < .04. Fourthly, there was no statistically
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significant difference in the microbiome composition of infants fed either exclusively
formula or a combination of formula and breast milk. Finally, vaginal delivery was
associated with an increased abundance of the Bacteroides and Bifidobacterium taxa, and
a decrease in the Staphylococcus taxa versus cesarean delivery, p < .001 (Madan et al,
2016).
The importance of these findings can be overlooked at first blush. There is a wellestablished bond between breast-feeding and a lower probability for youth and adultonset obesity (Madan et al., 2016). Studies have validated this correlation, which is
mediated in part by the microbiome in early life (Madan et al., 2016). This mediation is
through the maternal production of oligosaccharides present in breast milk (Madan et al.,
2016). The oligosaccharides, in turn, promote Bifidobacterium growth in the infant’s
intestines. A decreased abundance of Bifidobacterium in infancy has been found to be
concomitant with an increased risk for being overweight at age 10 (Madan et al., 2016).
Thus, a vaginally delivered and exclusively breast-fed infant has the increased probability
of not becoming obese in later life.
To determine if the maternal diet affects the neonatal microbiome, Chu et al.
(2016) conducted a longitudinal cohort study. The cohort study was conducted to
establish the possibility that a high-fat maternal diet could impact the infant’s intestinal
microbiome. Chu et al. prospectively enrolled 163 women during their third trimester and
the intra-partum period. A subgroup of 81 maternal-neonate pairs consented to
longitudinal sampling from the post-partum period through six-weeks. In order to
determine maternal dietary patterns the Dietary Screener Questionnaire (DSQ),
developed by the National Health and Examination Survey (NHANES), was utilized
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(Chu et al., 2016). After the questionnaires were scrutinized, the cohort was further
subdivided into two smaller groups. One group, the control group, consisted of 13
participants who consumed a low-fat diet. The other group of 13 participants consumed a
high-fat diet. To determine the infants’ microbiome, the meconium stool samples were
collected at 24-48 hours after delivery and again at six-weeks of age (Chu et al., 2016).
The results of the study revealed that 103 bacterial taxa were identified in the
meconium despite the short exposure time to the maternal and environmental bacterial
communities. Gene sequencing of the bacterial DNA within neonatal meconium
uncovered a relative depletion of the Bacteroides taxa, which was correlated with a highfat diet during gestation. The stool samples collected at the six-week mark revealed that
exposure to a maternal high-fat diet was significantly associated with an abundance of the
Enterococcus taxa and a relative reduction of the Bacteroides taxa (Chu et al., 2016).
The correlation between a maternal high-fat diet and the infants’ microbiome
composition after delivery is not surprising, but a high-fat diet during gestation causing
an altered gut microbiome in the infant is unanticipated. The researchers compared the
meconium bacterial samples with those collected at six-weeks of age and found that there
were significant differences at the phylum level. The researchers concluded that this
finding represents a broad rearrangement of the gut microbiota during this period of time
(Chu et al., 2016). Further, it is hypothesized that an increased consumption of animal
proteins persistently altered the continuum of commensal bacteria indigenous to the
digestive tract, namely Bacteroides fragilis (Chu et al., 2016). Bacteroides fragilis is
inherited from maternal fecal material during natural childbirth, and its colonization in
early life is correlated with a lower body mass index in later life (Chu et al., 2016).
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A longitudinal cohort study was conducted to evaluate the associations between
caesarean delivery and child body mass (Blustein et al., 2013). The study enrolled 10,219
children born from 1991 to 1992; of these children, 926 were delivered by caesarean
section. These children were followed from the age of six weeks until 15 years of age.
This study found that infants born via caesarean section had lower birth weights
than those born vaginally. Interestingly, in the study’s mixed multivariable models, when
adjusting for birth weight, socio-demographics, gestational factors, and feeding patterns
the children born via caesarean section were consistently associated with increased
adiposity (Blustein et al., 2013). This increase of adiposity began at six-weeks of age and
continued through age 15 (Blustein et al., 2013). Also, caesarean delivered children had
1.83 times the odds of increased adiposity and obesity as their vaginally delivered
counterparts (Blustein et al., 2013).
These findings support the hypothesis of caesarean delivered children exhibiting a
microbial dysbiosis resulting from bacterial colonization from maternal skin and the
procedural environment, which has been associated with a delayed Bacteroides
colonization in early life (Chu et al., 2016) Alternatively, children born vaginally were
generally the least likely to develop obesity. This corresponds to the likelihood that
vaginally born children are exposed to the maternal vaginal, and to an extent the maternal
fecal, microbiome during birth, and thus later life adiposity is reduced (Chu et al., 2016).
An observed weakness of this study is in the fact that the researchers did not sample the
subject’s intestinal microbial communities to ascertain any differences in the caesarean
delivered children versus those vaginally delivered.
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Early life is a precarious period for the microbial colonization of the infant’s
intestinal tract. The early microbial colonization of the human can be altered by delivery
methods, infant feeding practices, and the maternal diet. One other mechanism can
interrupt, or disrupt the infant’s gut colonization by commensal bacteria and that
mechanism is early antibiotic introduction.
Trasande, Blustein, Liu, Corwin, Cox, & Blaser (2013) conducted a longitudinal
birth cohort study of 11,532 children born in Avon, UK. This particular study was part of
a much larger study named the Avon Longitudinal Study of Parents and Children
(ALSPAC). Their study examined the influence of infant antibiotic contact and its impact
on early life adiposity.
The children were examined at less than six months of age, six to fourteen months
of age, and fifteen to twenty-three months of age. Children who were exposed to
antibiotics before the age of six months were at significantly greater odds of being
overweight at 38 months and at seven years of age (Trasande et al., 2013). When
maternal weight was analyzed, infants with mothers at a normal weight experienced
greater effects. These infants, when exposed to antibiotics before six months of age had a
29.4% increase in overweight (Trasande et al., 2013).
This study highlights and reinforces the concerns regarding infant antibiotic
exposure. The vulnerable period for the infant is before the age of six months. There are
limitations to this study as the results can be confounded by social, environmental, and
biological factors. One simple social factor to be taken into account is the ability of the
mother to have adequate memory recall of the infant’s antibiotic use.
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Microbial Interaction with the Human Host
The human, and his or her microbiome, comprises a thought-provoking
relationship a symbiotic relationship that lasts the humans’ entire lifespan. This
conglomeration of human and microbial cells constitutes what can be termed as a superorganism. The human super-organism is comprised of over 100 trillion cells, and each of
these cells contains genetic material (Cantarel, Lombard, & Henrissat, 2012). The
estimated number of microbial genes, housed just within the human gut, is approximately
3.3 million, while the entirety of the human genome consists of only 19,000 to 20,000
genes (Slyepchenko et al., 2016). A revelation comes with the knowledge that the
microbial cells outnumber the human host cells by a factor of ten to one (Dominianni et
al., 2015). This extraordinarily large disparity between human and microbial cells, and
human and microbial genomes raises the question, do the bacterial cells influence the
human host?
In 2016, Slyepchenko et al. authored a systematic review of the literature. The
review was conducted to explore the role of an altered gut microbiome and its
relationship to major depressive disorder, obesity, and type 2 diabetes. A total of 207
articles from PubMed and MEDLINE searches were examined. The outcome of this
study begins with how bacterial cells interact with the human host.
Normally, 90% of the intestinal microbial community is made up of Bacteroidetes
and Firmicutes and is often expressed as a ratio (Slyepchenko et al., 2016). When there is
an intestinal microbial dysbiosis, the ratio of Bacteroides to Firmicutes is altered, and
Firmicutes and other sub-dominant phyla can then exert their influence (Slyepchenko et
al., 2016). The review points out that the diet sculpts the structure of the gut microbiome
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throughout the human lifespan (Slyepchenko et al., 2016). The increase in dietary highfat foods can result in an altered gut microbiome and contribute to a vicious cycle of lowgrade inflammation and weight gain. Thus, obesity has an underlying pathophysiology of
chronic low-grade inflammation brought about, in part, by the gut bacteria.
The reduction in the Bacteroidetes phyla, as a result of high-fat dietary intake,
results in a decrease in the production of butyrate. Butyrate is a short chain fatty acid that
is responsible for preserving mucin production in the colon, sustaining tight epithelial
junctions within the intestines, tempering intestinal epithelial proliferation, and the
inhibition of NF-KB, which by the inhibition supports intestinal barrier integrity
(Slyepchenko et al., 2016). The reduction in the abundance of Bacteroidetes allows for
an increased incidence of the translocation of bacterial cells, bacterial chemokines, and
bacterial genetic material through the intestinal epithelial matrix junctions and into the
host circulation (Slyepchenko et al., 2016).
The incursion of bacterial products into host circulation inaugurates the
inflammatory cycle. The numerous chemokines in circulation within the obese individual,
as a direct consequence of an altered gut microbiome, includes: IL-1B, IL-6, C-reactive
protein, soluble IL-2 receptor, TNF-alpha, plasminogen activator inhibitor, and serum
amyloid A (Slyepchenko et al., 2016). Also of importance, are the obese individuals’
elevated serum levels of lipopolysaccharides. Lipopolysaccharides (LPS) are the
components of bacterial cell walls and directly lead to adipose tissue inflammation
(Slyepchenko et al., 2016).
The mechanisms by which bacteria exert their influence on the human have not
been fully elucidated, but numerous concerted efforts have taken place. To examine the
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link between the gut microbiota and adipose tissue inflammation Pekkala et al. conducted
a longitudinal cohort study published in 2015. The cohort consisted of eight women
recruited from the Finnish Academy SKID-KID program (Pekkala et al., 2015).
The study examined Toll-like receptors (TLR) of the cohort’s participants.
Participants were grouped according to having either low TLR5-signaling pathway genes
(L-TLR), or those with high TLR5-signaling pathway genes (H-TLR). There were four
participants in each group. The H-TLR participants were heavier, had higher body mass
indices, greater waist circumferences, higher systolic blood pressures, and elevated serum
levels of leptin, LDL, and triglycerides (Pekkala et al., 2015). The H-TLR groups’
abdominal adipose tissue biopsies revealed their genome had 419 up-regulated and 249
down-regulated genes directly related to altered metabolism and increased inflammation
(Pekkala et al., 2015).
The H-TLR group had a recognizable intestinal dysbiosis that was statistically
significant (Pekkala et al., 2015). The dysbiosis was seen as a higher Firmicutes to
Bacteroidetes ratio, higher sub-phyla abundances of flagellated Clostridium, and lower
Bifidobacteria. The resultant dysbiosis lead to translocation of bacterial products into
host circulation. The inflammatory process ensues from the lipopolysaccharides
activating the TLR5 pathway, and as a direct consequence leads to adipose tissue
hypertrophy and macrophage infiltration into adipose tissue (Pekkala, et al., 2015).
Interestingly, the study uncovered evidence that the simple ingestion of a high-fat diet
resulted in TLR1, 5, 8, 9, and 12 pathways being over-expressed in the visceral adipose
tissue (Pekkala et al., 2015). One other caveat, the study highlighted the consequences of
the increased abundances of a sub-phylum, such as Clostridium. Clostridia are short
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chain fatty acid (SCFA) producers, and as a result, these bacteria increase the total
number of calories extracted from undigested foods and increase lipogenesis. In short,
these bacteria contribute to energy harvesting and increase the serum lipids for their
human host (Pekkala et al., 1015).
In the framework of gut barrier integrity, a high-fat dietary intake can cause
epithelial disruption and intensify intestinal permeability. Lau et al. (2016) examined the
function of intestinal fatty acid binding protein (I-FABP) as a potential biological marker
of intestinal barrier dysfunction. The study subjects were 12 Wistar rats randomly divided
into two groups of six. One group was fed a standard diet (SD), and the second group was
fed a high-fat diet (HF). The rats were utilized because their gut microbiota is similar to
humans (Lau et al., 2016).
The results confirm earlier studies and are statistically significant, p < 0.05. The
HF group had lower Bacteroides taxa and a higher Firmicutes to Bacteroides ratios. The
Firmicutes to Bacteroides ratio was positively correlated with weight gain the HF group.
As a consequence of the HF diet and higher Firmicute abundances the intestinal barrier
function was diminished. Serum lipopolysaccharides (LPS) were elevated in the HF
group and were positively correlated with the increased abundance of Firmicutes (Lau et
al., 2016). The high-fat diets caused obesity, and as a result, triggered a dysbiosis of the
rats’ intestinal gut microbiome. The resulting dysbiosis increased the host’s TLR4
pathway gene expressions and contributed to the increase in LPS causing higher
circulating pro-inflammatory chemokines (Lau et al., 2016). The hypothesis put forth by
this study suggests that a high-fat diet up-regulates genes known to enhance SCFA
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synthesis and uptake, and promote chronic low-grade inflammation via gut microbiome
manipulation (Lau et al., 2016).
The distorted gut microbial populations of the obese can impact the host in
seemingly innocuous ways when viewed on the macro-scale. When viewed on the microscale, the gut microbiome responds to the hosts’ preferences in food choices, and as a
result, these food choices initiate a cascade of changes to the host. These changes include:
increasing adiposity deposits, alterations in host energy scavenging, deregulation of the
intestinal barrier function, and shifting the composition of the dominant phyla within the
hosts’ gut. Ravussin et al. (2012) conducted a randomized controlled trial to investigate
the impact of a 20% reduction in weight on the gut microbiota of diet-induced obese
mice. The study was conducted to reveal any responses of the obese mice’s intestinal
bacteria to diet composition and weight loss.
The researchers divided 32 mice randomly into four groups of eight. The groups
were then fed a controlled diet, and labeled as diet induced obese mice, control diet fed
mice, weight-reduced to 20% below initial weight mice, and weight-reduced control diet
mice (Ravussin et al., 2012). The results specify that different diets foster diverse
bacterial communities, and that weight reduction modifies the gut microbial community
of diet induced obese mice, but not of mice fed a control diet (Ravussin et al., 2012).
More specifically, the diet induced obese mice had higher abundances of Firmicutes, and
a significant reduction in the circulating host serum leptin levels (Ravussin et al., 2012).
The act of consuming a high-fat diet leads to a change in dominant bacterial phyla within
the hosts’ gut, and is not related to the caloric intake (Ravussin et al., 2012). The serum
leptin levels were highly correlated to total fat mass and circulating leptin levels declined
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approximately 80% in the diet induced obese mice when compared to the control fed
mice.
The study established that the gut microbiota influence the host through the
translocation of bacterial products via the disrupted intestinal epithelial barrier. The
translocation of bacterial products, namely lipopolysaccharides, induces a chronic lowgrade inflammatory cycle evident in white adipose tissue gene expression (Ravussin et
al., 2012). The study acknowledged that the host microbiota would contribute to host
adiposity through energy harvesting. Energy harvesting takes place in the large intestines
via microbial breakdown of undigested complex polysaccharides and increased
production of SCFA (Ravussin et al., 2012). This process, in turn, gives the host an
increase in total caloric and fatty acid intake (Ravussin et al., 2012).
Shoaie et al. (2013) conducted a descriptive correlational study aimed at
identifying the relations between the human microbiota through metabolic modeling.
Three genome-scale metabolic models were utilized, which represent the three most
common phyla of microbial life in the human intestine. These microbes include:
Bacteroides thetaiotamicron, Eubacterium rectale, and Methanobrevibacter smithii
(Shoaie et al. 2013). These organisms are more commonly referred to as Bacteroides,
Firmicutes, and Archaea. Interestingly, this study was carried out via mathematical
models, super-computer simulations, and genomic algorithms.
The mathematical model predictions identified increased SCFA production that
was correlated with the increased abundances of the Firmicute, Eubacterium rectale
(Shoaie et al., 2013). The production of butyrate, a SCFA, increased when Bacteroides
thetaiotamicron was co-colonized with Eubacterium rectale. The increased production

THE ROLE OF THE INTESTINAL MICROBIOTA IN OBESITY

20

of this SCFA is associated with colon cancer, diabetes, and obesity (Shoaie et al., 2013).
The mathematical model also discovered that the hosts’ glutamine was taken up by E.
rectale and converted to glutamate. This increased utilization of glutamine by the
Firmicutes results in decreased serum levels of this nitrogenous product correlating with
increased incidences for diabetes and metabolic syndrome for the host (Shoaie et al.,
2013).
The Microbiota’s Contribution to Obesity
Studies in mice and humans specify that the intestinal microbiome change both
sides of the energy-balance calculations by promoting nutrient absorption and regulating
host gene expression altering adiposity. There remains an ambiguity as to what extent the
intestinal microbiota regulates nutrient absorption in humans. Jumpertz et al. (2011)
conducted a single randomized clinical trial examining how the gut microbial community
arrangement is affected by the nutrient load.
Twelve lean individuals with a body mass index of 18.5 to 24.9 and nine obese
individuals with a body mass index of greater than 30 were randomly assigned a 2400kcal diet or a 3400-kcal diet (Jumpertz et al., (2011). Fecal samples were taken before
and at scheduled intervals during the experiment. The Bacteroides and Firmicutes
represented 97% of the sequenced genomes (Jumpertz et al., 2011). The prevailing classlevel representatives of the Bacteroides and Firmicutes were Bacteroidetes and
Clostridia, and this representation was irrespective of the experimental diet (Jumpertz et
al., 2011).
The results of the nine-day experiment were noteworthy. The researchers not only
looked at the various bacterial genomes, but also the caloric loss experienced through the
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expulsion of stool. The lean subjects lost relatively less energy in stools with the 3400kcal diet than with the 2400-kcal diet (Jumpertz et al., 2011). Also, the lean subjects
assigned the high caloric intake experienced rapid phylum level changes after only three
days (Jumpertz et al., 2011). A 20% increase in the abundances of the Firmicutes was
noted in the high caloric intake of the lean and obese subjects, and an increased nutrient
absorption of approximately 150-kcal per day (Jumpertz et al., 2011). The increased
nutrient load induced rapid changes in the gut microbial communities and hints at the
possibility that the microbiome senses the alterations in the nutrient availability and
subsequently modulates the hosts’ absorptive capabilities.
Semova et al. (2012) examined how the gut microbiota and dietary fat intake
interact to regulate lipid absorption in the intestinal epithelium. Zebra fish larvae were
randomly assigned to be incubated conventionally or as germ-free. The researchers
“…developed a method to monitor fatty acid absorption into the gut epithelium by
incubating the fish in liposomes containing fatty acid analogs that are fluorescently
labeled” (Semova et al., 2013). The fish were used due to their digestive tract physiology
and anatomy, and their lipid metabolism being analogous to mammals and other
vertebrates.
The outcomes of this study ascertains that the colonization of the gut by bacteria
promotes epithelial absorption of fatty acids and results in the accumulation of lipid
droplets in the enterocytes and extra-intestinal tissues (Semova et al., 2013). Furthermore,
the phyla of Firmicutes were developed in the intestines of fed fish, where they
augmented the proficiency of the host enterocytes to absorb fatty acids (Semova et al.,
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2013). As a result, the amplified abundance of Firmicutes is positively correlated with
dietary intake.
Wu et al. (2011) organized a quasi-experimental randomized clinical trial in an
effort to associate long-standing dietary models with gut microbial ecosystems. The
experiment had a ten-day duration and consisted of ten participants who were randomly
selected from a pool of 98 healthy potential subjects (Wu et al., 2011). The participants
were segregated in a hospital setting and were randomly selected to consume one of two
diet types. One diet type included a high fat, low fiber diet, while the other diet consisted
of low fat and high fiber (Wu et al., 2011). Stool samples were collected at the onset and
at predetermined intervals during the study.
The results were similar to other previous study outcomes. The ten participants, at
the onset, exhibited predominately a Bacteroides phyla within their respective intestinal
microbial ecosystems, while only one self-reported vegan displayed a Prevotella phyla
(Wu et al., 2011). There were no reported abundances of Firmicutes. During the
controlled feeding study the group consuming the high fat low fiber diet had significant
microbial ecosystem perturbation within the initial 24 hours of the study (Wu et al.,
2011). Despite the initial distress, the dominant phyla within the respective microbial
ecosystems did not succumb to sub-phlya population excursions (Wu et al., 2011).
Notably, the study identifies nutrients from fat versus plant products and fiber to exhibit
an inverse association with the microbial taxa (Wu et al., 2011). The hypothesis, put
forth, was only the hosts’ long-term diet choices would cause a significant change to
microbial ecosystem domination from one phyla to another.

THE ROLE OF THE INTESTINAL MICROBIOTA IN OBESITY

23

A human’s intestinal microbiome consists of more than bacteria. The microbiota
contains bacteria, archaea, viruses, yeasts, fungi, and bacteriophage products. A
relationship exists between archaea, fungi, and bacteria. These microbial species form a
symbiotic population, in which the metabolic waste from one microbe provides nutrients
for another. Thus, other constituents may alter a human’s microbial ecosystem. Hoffman
et al. (2013) carried out a longitudinal cohort study to identify the archaea and fungi of
the human gut microbiome and relate them to the diet and the bacterial occupants.
Ninety-eight healthy participants completed dietary inventories with the Willett food
frequency questionnaire, and provided stool samples for 16S rRNA gene sequencing
(Hoffman et al., 2013).
All fecal samples tested positive for at least one archaeal genera with 44 of the 96
samples having five archaeal genera (Hoffman et al., 2013). All fecal samples produced
fungal sequences with a detection of 66 known genera and 16 uncategorized genera
(Hoffman et al., 2013). The most common archaea were Methanobrevibacter and
Nitrososphaera, and the most common fungi were Saccharomyces, Candida, and
Cladosporium (Hoffman et al., 2013). Three microbial genera were identified with a high
proportional intake of carbohydrates, and these were Methanobrevibacter, Prevotella,
and Candida (Hoffman et al., 2013). The study identifies Candida as having the ability to
degrade undigested carbohydrates to liberate simple sugars, which in turn are fermented
by bacteria and absorbed by the host, thereby contributing to energy harvesting.
Obesity is not a transient condition, but is a chronic disease process marked by
persistent high calorie intake and an abnormal intestinal microbial ecosystem. Obese
individuals have been shown to have an altered Bacteroides to Firmicutes ratio as a result
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of high fat dietary choices (Lau et al., 2016). The dietary preferences of the human host
play a pivotal role in the intestinal microbial community composition with changes
occurring in as early as 24 hours (Wu et al., 2011). This raises the question; can chronic
dysbiosis be remedied by the initiation of long-term dietary changes? Simoes et al. (2014)
managed a longitudinal cohort study to consider the influence of a low energy diet on the
intestinal microbiota of obese participants. The cohort consisted of 16 obese participants
who consumed a very low energy diet (VLED) for six weeks, followed up after five,
eight, and twelve months, and submitted fecal samples at predetermined intervals
throughout the study (Simoes et al., 2014). In addition, the six males and ten females
participated in individual and group exercise and lifestyle counseling (Simoes et al.,
2014).
The bacterial phyla in the greatest abundance among the obese participants at the
baseline included: Clostridial clusters XIVa, XIVb, and IX, Faecalibacterium prauznitzii,
and Bifidobacteria (Simoes et al., 2014). It was not until the end of the six-week VLED
period that there were significant reductions in Clostridia, Bifidobacteria, and
Lactobacillus and significant increases in the sub-phyla of Bacteroides among the obese
participants (Simoes et al., 2014). It was hypothesized that the reduction in carbohydrate
intake reduced the substrates available to Bifidobacteria and Lactobacillus, thereby
decreasing SCFA production. Also, the reduction of the Clostridia phyla decreased total
energy harvesting (Simoes et al., 2014). The conclusion of the study, after twelve months,
resulted in an average weight loss of nine kilograms and a total decrease in energy intake
by 64.6% (Simoes et al., 2014). Also, at the conclusion of the study, all bacterial phyla
groups tended to increase except for Bacteroides (Simoes et al., 2014). This could
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indicate that the participants may have reverted back to their familiar and common foods
consumed prior to the study’s initiation. Ultimately, the cohort study corroborates the
notion that an alteration of the dietary intake provokes changes in the intestinal microbial
ecosystems.
One of the most abundant food and nutrient sources includes simple and complex
carbohydrates. Human digestive enzymes are capable of degrading simple carbohydrates,
but are unable to breakdown the majority of the complex carbohydrates found in most
plant based foods. The complex cellular structures of most plant cell walls do not lend
themselves readily to enzymatic breakdown. Cantarel, Lombard, & Henrissat (2012)
conducted a longitudinal cohort study with 148 participants to examine how complex
carbohydrates are degraded by bacteria in the human gut. The categorized human genome
data were analyzed and the microbial gene sequences were considered in relation to
complex carbohydrate utilization.
The 148 participants collected bacterial samples from five different body sites
including the stool. A total of 520 samples were analyzed utilizing shotgun
metagenomics and 16S rRNA sequencing of the bacterial genome (Cantarel et al., 2012).
After data processing, it was revealed that the human genome only encodes for 97
glycoside hydrolases (GH) with only 17 known enzymes existing for carbohydrate
breakdown (Cantarel et al., 2012). Conversely, one bacteria species alone, Bacteroides
thetaiotaomicron encodes 260 glycoside hydrolases (GH) for carbohydrate breakdown
(Cantarel et al., 2012). The oral samples collected provided bacterial samples yielding
bacteria capable of enzymatic degradation of carbohydrates. No longer is salivary
amylase the only enzyme available for initial carbohydrate digestion. The bacterial
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enzymes contained within the oral cavity include: GH6, GH26, GH28, and GH43
(Cantarel et al., 2012). Notably, these enzymes are nonexistent in the human genome
(Cantarel et al., 2012). It was observed that the human microbiome is more specialized in
the area of carbohydrate metabolism than that of animal protein or animal carbohydrate
(Cantarel et al., 2012).
Multiple variables must be taken into account when looking at the intestinal
microbiome. The diet, antibiotic exposure, logistics, birth method, and early life bacterial
exposures are all factors of what constitutes the intestinal microbial community.
Dominianni et al. (2015) explored another avenue. Dominianni et al. studied 82
participants to identify a correlation between gender, body mass index, and dietary fiber
intake with the intestinal microbiome.
There were 51 men and 31 women comprising this study, and it was found that
women had significantly different intestinal microbial compositions overall (Dominianni
et al., 2015). Women in general had lower populations of Bacteroides than men,
especially those female individuals who were obese (Dominianni et al., 2015). The
hypothesis was that estrogen might play a role in gut microbial populations. These
findings were congruent with earlier studies, which identified lower Bacteroides
populations in obese versus normal weight female twins (Turnbaugh et al., 2009 &
Dominianni et al., 2015). Adipose tissue is not an inert substance, but an active organ
with endocrine excreting qualities. Once such product of adipose tissue is estrogen. This
study identifies that obesity decreases the Bacteroides, but so too does higher serum
levels of estrogen (Dominianni et al., 2015). Thus, the body mass index could be a
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mediating factor as the increasing adiposity modulates the gut microbiome though
estrogen production.
Kulecka et al. (2016) conducted a randomized controlled trial utilizing 48 male
mice. The study considered the modifications of the gut microbiota under long-term
contact with a high-fat diet. Mice are utilized due to the similarities of the human and
mouse intestinal microbiota (Kulecka et al. 2016). The mice were randomly selected and
sequestered into three groups of 16. One group was fed a normal diet (ND), one group
was fed a high-fat diet (HFD), and one group was fed a high-fat diet supplemented with
feces from the ND mice (HFDS).
After data processing, the most abundant bacterial phyla at the onset of the study
was the Bacteroidetes with 70.6%, Firmicutes with 22.5%, and Proteobacteria with 4.8%
of the bacteria population (Kulecka et al., 2016). After the twelfth week, both HFD and
HFDS mice were obese and exhibited significant increases in the abundances of
Firmicutes and Actinobacteria, more commonly known as Clostridia and Bifidobacteria
(Kulecka et al., 2016). Interestingly, obesity in the mice was associated with an increase
in both Bacteroidetes and Firmicutes, and persistent conveyance of the ND gut bacteria
to the HFD mice hastened the onset of obesity and augmented adiposity (Kulecka et al.,
2016).
Kong et al. (2013) conducted a longitudinal cohort study of 30 obese women
enrolled in a bariatric surgery program. The study was conducted to ascertain the
probability of gut microbial changes after a Roux-en-Y gastric bypass procedure. Of the
30 participants, seven were diabetic and 23 were non-diabetic. Stool samples were
collected at the initiation of the study and at predetermined intervals after the procedure
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(Kong et al., 2013). Periumbilical adipose tissue samples were acquired at
commencement and three months post-procedure (Kong et al., 2013). Genetic studies
were carried out utilizing 16S rRNA sequencing for bacterial identification and Agilent
2100 Bioanalyzer for human adipose samples (Kong et al., 2013).
Upon completion of the study, it was revealed that 58 bacterial genera that had
been undetectable before the gastric bypass were detected three months post-procedure
(Kong et al., 2013). These previously undetected genera were transient species from the
periodontal and oropharyngeal ecosystems. Intestinal bacterial phyla that increased after
the gastric bypass included Bacteroides, Alistipes, and Proteobacteria. The phyla that
decreased after the procedure included Firmicutes and Actinobacteria (Kong et al., 2013).
The most notable data concerns the gene expression exhibited in the white adipose tissue
samples. The study revealed 153 white adipose tissue genes, garnered from adipose tissue
sampling, which revealed human gene expression was associated with at least one
bacterial species (Kong et al., 2013). This alludes to the fact that the bacteria may
influence human gene expression.
Walters, Xu, & Knight conducted a meta-analyses of available microbial
associated obesity literature. The researchers examined data compiled using the QIIME
database. The QIIME database is a repository for genetic based studies relating to the
microbiome (Walters, Xu, & Knight, 2013). The analysis reveals that the microbial
communities within the human are not the sole contributors to obesity, but alterations in
the intestinal microbiome are observed in obese humans (Walters et al., 2013). Moreover,
significant microbial differences are apparent and the ability to classify individuals as
obese or lean based on dominant bacterial phyla has a 90% accuracy rate (Walters et al.,
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2013). Studies promoting one bacterial phyla over another have resulted in contradictory
results. Many studies identify an increased Firmicutes to Bacteroides ratio as a sign of
dysbiosis within the human gut, but other studies may show no tendency, or even an
opposite inclination (Walters et al., 2013). The study by Walters, Xu, and Knight
compared the means of the ratios for subjects with a normal versus an obese body mass
index and in all studies but one there was a tendency showing an increased Firmicutes to
Bacteroides ratio. Conversely, no significant disparities between obese and lean subjects
were found using Wilcoxon rank sums tests, nor was the variance in Firmicutes to
Bacteroides ratio statistically significant using Fisher’s Method for combining multiple
independent tests of a hypothesis (Walters et al., 2013).
Obese individuals have been described as having a less diverse intestinal
microbiome than normal weight individuals, but the results of this meta-analysis imply
that the density of a bacterial community does not commonly differentiate these
communities (Walters et al., 2013). As a result, the study outcomes are much larger than
the biological influences separating the lean from the obese human, and herald the need
for more regulation of variables among the studies (Walters et al., 2013).
Summary of the Literature
The gut microbiota communally act as a metabolic structure supplying resources
for themselves and for the host they populate (Cantarel et al., 2012). How the human
acquires this symbiotic bond is dependent on the mother’s gestational diet, birthing
method, and feeding practices and is in a continual state of flux throughout the lifespan
(Madan et al., 2016; Chu et al., 2016; & Blustein et al., 2013). Moreover, in the infant to
childhood timeframe, how the human cultivates the optimal balance of Fermicutes to
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Bacteroides ratio is dependent on the avoidance of early life antibiotic exposures
(Trasande et al., 2013 & Lau et al., 2016). The avoidance of unnecessary early life
antibiotic exposures assists the growth and development of not only the human, but the
microbiome as well. As the human, and their microbiome, grows and matures, the
process of maintaining low fat, high fiber dietary choices is paramount to the overall
health of each (Dominianni et al., 2015).
We live in a mutual coexistence with our gut microbiota, but this affiliation
occasionally becomes pathological, such as in obesity (Wu et al., 2011). The prevailing
wisdom has been grounded on evidence that an increase in caloric intake coupled with a
decrease in physical activity results in weight gain (Simoes et al., 2014). While this is
true, it is not solitary dogma. There is evidence, which directs towards an environmental
factor in the obesity epidemic. This environmental factor involves the increased energy
harvesting capabilities by the intestinal bacteria promoting greater caloric availability to
the host, thus allowing for prodigious adiposity stores (Simoes et al., 2014). Also,
research has elucidated that obesity is associated with, and results in, phylum level
changes in the intestinal microbial populations, an alteration of bacterial and human gene
expressions and their respective metabolic pathways, and a diminished intestinal
microbial diversity (Turnbaugh et al., 2009). In effort to assist in combating the obesity
epidemic, the medical provider can accomplish effective mediation through education on
the microscopic co-inhabitants. Not surprisingly, this education includes: increasing the
number of vaginal deliveries, reinforcing the need for breast feeding, decreasing
unnecessary antibiotic administrations, adopting a long-term low fat, high fiber dietary
choices, and committing to long-term regular exercise.
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Limitations
The limitations to this literature review are noteworthy to the nurse practitioner.
Firstly, many of the available research studies utilized small sample sizes. The
consequence to small sample sizes is the difficulty in finding significant relationships
from the data. Secondly, many of the available studies utilize animal models to study the
intestinal microbiota. The potential complexities that may arise include human versus
animal dissimilarities in gut structure and function, as well as environmental variables.
The statistical significance of the data in the animal models studied can be skewed if all
pertinent variables are not accounted for. Next, large scale randomized controlled trials
from the literature are few. Also, of the large-scale studies conducted, the majority are
observational cohort studies where data regarding obesity and the microbiome are
inferred. Finally, the precipitous complexity of DNA sampling techniques, genome
mapping, and the interpretation of genome data can be daunting. The lack of a substantial
background in the sciences of biology and chemistry may, or will limit the nurse
practitioner’s understanding of the intricacies of intestinal microbe genome data and its
potential application to the population.
Recommendations for Advance Practice
In consideration of advanced practice, it is recommended that advanced practice
nurses work closely with obese patients in developing educational interventions with
long-term goals in mind. Distinctively adapted mediations must be created to fit the needs
of each specific patient. It is essential that the advanced practice nurse perform a needs
assessment with the patient in order to recognize where education is warranted. One such
area includes ongoing patient and community education regarding unnecessary antibiotic
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usage. One other method, to ensure an optimal bacterial colonization, is the education on,
and the encouragement for, vaginal deliveries. The education and encouragement for a
vaginal delivery is not only for the individual, but also with respective medical providers.
When any applicable interventions have been implemented for the patient, the
advanced healthcare provider must reassess the patient and establish if successful
education is evident. If the long-term interventions are not met, they must be modified to
meet the requisites of the patient. The ultimate objective of the education intervention is
to allow the patient to make informed decisions regarding birth methods, maternal lowfat diet, restrictive antibiotic usage in the very young, life-long low-fat high fiber dietary
choices, and life-long exercise.
Recommendations for Future Research
Future research is obligatory to better understand the microbiome’s impact on
obesity. This review of literature focused only on three concepts for the advanced
practice nurse: how the microbiome is acquired, how the microbiome interacts with the
human, and how the microbiome may contribute to obesity. Research should be
performed that examines cognitive factors, emotional factors, social factors,
developmental factors, and spiritual aspects of the obese patient.
Moving onward, research studies looking specifically at larger sub-sets of the
obese population should be conducted, which examines specific geographical areas,
cultural tendencies, individual genome mapping, and individualized intestinal
microbiome genome identification. Simply put, higher numbers of research studies
examining the microbiota and obesity are desirable. This is especially true regarding the
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validation of earlier studies, studies utilizing animal models, and studies with very few
participants.
Conclusion
The gut microbiota collectively act as a metabolic organ supplying energy for
themselves and for the host they inhabit. This symbiotic relationship begins at the onset
of a human birth and continues throughout the lifespan. The probability of the microbiota
making a contribution to obesity is high. As human beings, we have the capacity to limit
the effects of our mutualistic microbial partners, but a change in methodologies is
needed. The change requires the human to acknowledge the microbiota as necessary
cohabitates, and not an entity to be decimated. Finally, the nurse practitioner can be a
trailblazer in this paradigm shift by equating the microbiome to a garden, where the
microbes are cultivated and not annihilated. It is not survival of the fittest, but mutual
coexistence with a numerically superior force.
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